The emergence of RNA-based therapeutics demands robust and economical methods to produce RNA with few byproducts from aberrant activity. While in vitro transcription using the bacteriophage T7 RNA polymerase is one such popular method, its transcripts are known to display an immune-stimulatory activity that is often undesirable and uncontrollable. We here showed that the immune-stimulatory activity of T7 transcript is contributed by its aberrant activity to initiate transcription from a promoter-less DNA end. This activity results in the production of an antisense RNA that is fully complementary to the intended sense RNA product, and consequently a long double-stranded RNA (dsRNA) that can robustly stimulate a cytosolic pattern recognition receptor, MDA5. This promoter-independent transcriptional activity of the T7 RNA polymerase was observed for a wide range of DNA sequences and lengths, but can be suppressed by altering the transcription reaction with modified nucleotides or by reducing the Mg concentration. The current work thus not only offers a previously unappreciated mechanism by which T7 transcripts stimulate the innate immune system, but also shows that the immunestimulatory activity can be readily regulated.
INTRODUCTION
demonstrate that T7 pol often generates a high level of unintended double-stranded RNA (dsRNA) that are highly immune-stimulatory and made of the intended sense transcript and its fully complementary antisense transcript. The current work offers a previously unappreciated mechanism by which T7 transcripts stimulate the innate immune system, and a method to suppress such dsRNA byproduct formation.
RESULTS

In vitro T7 transcription often generates dsRNA byproduct from a template designed for ssRNA
To examine the immune-stimulatory activity of T7 transcripts, we performed in vitro transcription of four independent RNAs, and tested their RIG-I/MDA5-stimulatory activities using the interferon-promoter driven dual luciferase assay in 293T cells. These transcripts were generated from templates that are designed to produce 512 nt ssRNAs with limited secondary structures (512A, 512B, 512C and 512D, see Table S1 ). Since 293T cells express a low level of RIG-I and little or no MDA5, we transiently expressed RIG-I or MDA5, stimulated the cells by transfecting RNAs of interest, and measured the signaling activity of RIG-I or MDA5 by the level of the luciferase activity. A known stimulator, polyinosinic-polycytidylic acid (polyIC), was used for comparison. Consistent with previous reports about the immune-stimulatory activity of T7 transcripts, we observed that all four T7 transcripts robustly stimulated both RIG-I and MDA5 ( Figure 1A ). Treatment of these RNAs with Calf Intestinal Phosphatase (CIP), which removes 5'ppp, largely suppressed the RIG-I stimulatory activities, but not the MDA5stimulatory activities ( Figure 1A) .
To identify the origin of 5'ppp-independent MDA5-stimulatory activity, we analyzed the T7 transcripts by non-denaturing PAGE. Two bands were observed for all four RNAs tested, with the upper bands at an expected position near the 500 nt ssRNA marker, and the lower bands at a position near the 500 bp dsRNA marker ( Figure 1B) . While there were batch-to-batch variations in the relative levels of the two bands, they were the most prominent bands in all cases. The two bands displayed different fluorescence of acridine orange, a dye that binds RNA regardless of its secondary structure, but fluoresces differently depending on the RNA secondary structure 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 ( Figure 1B) . The upper band showed a similar fluorescent behavior as the 500 nt ssRNA marker (rendered orange in the gel image), while the lower band did as the 500 bp dsRNA marker (rendered green). The two bands also displayed different sensitivities to RNase I f and RNase III that are specific to ssRNA and dsRNA, respectively ( Figure 1C , only shown for 512B as a representative example). The upper band was susceptible to RNase I f , while the lower band was to RNase III. Consistent with this notion that the upper band is mostly single stranded, while the lower band has significant duplex structures, only the lower band RNA, as purified by the gel extraction or RNase I f digestion, had a significant stimulatory activity for MDA5-mediated antiviral signaling ( Figure 1D ). In vitro analysis of the interaction between the upper or lower band RNAs of 512B and MDA5 also showed that only the lower band can stimulate MDA5 filament formation and its ATPase activity ( Figures 1E & 1F ). Intriguingly, electron microscopy analysis of the MDA5 filament showed that the lower band RNA supported formation of ~150-160 nm long MDA5 filament ( Figure 1E ), a length expected for ~500 bp dsRNA (15) . This suggested that the lower band is not the intended ssRNA with an intrinsic secondary structure, but is instead a ~500 bp dsRNA byproduct.
dsRNA byproduct results from antisense transcription from the promoter-less DNA end
Previous studies reported that T7 pol can generate erroneous products by extending the 3' end of the RNA with the sequence complementary to the intended RNA product (16) . Such byproducts would fold onto themselves and form a hairpin structure with its duplex size equivalent to that of the intended ssRNA. To examine whether the ~500 bp dsRNA byproduct is produced in this fashion, we examined the 3' end sequence of the intended ssRNA transcript (512B) using 3'-RACE followed by Sanger sequencing (Figure 2A ). The sequencing result shows that the ends are well-defined although a few nucleotide heterogeneities were also observed, a well-known behavior of T7 pol. This result is inconsistent with the idea that a long complementary 3' extension is responsible for the observed ~500 bp duplex byproduct.
It was also reported that T7 pol can generate RNA using another RNA as a template (17, 18) . To examine this possibility and to determine exactly how the dsRNA byproduct was made, we performed 3'-and 5'-RACE analyses of the RNA complementary to 512B (c512B) ( Figure 2B ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The results showed that c512B starts primarily from the 3' end of 512B ( Figure 2C ). Note that the template sequence in this end has little resemblance to the canonical T7 promoter. 3'-RACE of the c512B further revealed that c512B ends with the sequence complementary to the T7 promoter. These results suggest that the c512B is produced by transcription in reverse orientation from the promoter-less DNA end of the 512B template, rather than by RNA-dependent RNA polymerization. To further confirm that c512B is synthesized by promote-independent, DNAdependent transcription, we performed the T7 transcription using 512B RNA as a template and 512B DNA template without the T7 promoter at either end. Consistent with the notion that c512B is generated from the promoter-independent, DNA-dependent RNA polymerization, dsRNA was generated from the DNA even without the T7 promoter, but not from the RNA template ( Figure 2D ). The transcription reaction using 512B RNA template did not produce any detectable level of dsRNA or transcription product aside from the input RNA.
Promoter-independent antisense transcription occurs for a wide range of DNA with various end sequences and structures
Our finding that promoter-independent T7 pol transcription begins at the promoter-less DNA end raised the question of whether this activity depends on the DNA end sequence or structure. Note that the four RNAs tested above (512A-D) have different sequences but share the common 6 nucleotides at the promoter-less end of the DNA template (Table S1 ). The templates were also commonly prepared by PCR amplification, and thus are expected to harbor blunt ends. To examine the importance of the DNA end sequence and structure, we compared three sequence variants that differ from the original 512B template near the promoter-less end (i.e. transcriptional start site for c512B) ( Figure 3A ). In the varied end sequence, we embedded unique restriction sites (XmaI, BamHI and KpnI), which enabled us to generate ends containing 5'-and 3'-overhangs by restriction digestion. The Klenow reaction was also performed to ensure that the original 512B template harbors blunt ends.
Comparison of the transcripts from these DNA templates before and after Klenow or restriction digestion suggests that the end sequence and structures can influence the efficiency of promoterindependent antisense transcription, as measured by the dsRNA byproduct on the native gel ( Figure 3B ) and MDA5 ATPase activity ( Figure 3C ). Note that the XmaI sequence lowered the level of dsRNA, whereas restriction digestion increased the level of dsRNA regardless of the sequence or overhang type. In particular, digestion with KpnI, which generates a 3' overhang, increased the level of dsRNA most significantly. While the higher level of dsRNA with KpnIdigested DNA is consistent with the previous report that a 3' overhang promotes antisense transcription (19) , our finding suggests that even DNA with a 5' overhang (BamHI-ad) or a blunt end (Klenow) have a significant level of antisense transcription. These results thus suggest that the promoter-independent antisense transcription is a more general phenomenon than was previously thought, and can be influenced, but not eliminated by both DNA end sequence and structure.
Modified nucleotides affect the level of dsRNA byproduct, not its MDA5-stimluatory activity
It has been shown that co-transcriptional incorporation of modified nucleotides can decrease to a certain extent the immunogenicity of T7 transcripts (4, 14, 20, 21) . These modified nucleotides include pseudouridine (Ψ), 1-methylpseudouridine (m1Ψ), -methyladenosine (m6A), and 5methylcytosine (m5C) ( Figure 4A ). We asked whether the presence of modified nucleotides suppress the formation of dsRNA byproducts or immune-stimulatory activity of the dsRNA. To test these hypotheses, we performed four independent transcription reactions, in each of which Ψ, m1Ψ, m6A or m5C completely replaced U, U, A or C, respectively. Intriguingly, Ψ, m1Ψ and m5C, but not m6A, suppressed dsRNA byproduct formation, as measured by native gel analysis ( Figure 4B ). The cellular MDA5 signaling activity and MDA5 ATPase activity also correlated with the level of dsRNA byproduct observed in the transcripts ( Figures 4C & 4D ).
We next asked whether incorporation of Ψ, m1Ψ, m6A or m5C has any effect on the dsRNA's ability to stimulate MDA5, in addition to the level of dsRNA byproduct formation. To address this question, we examined MDA5 signaling and ATPase activities using modified and unmodified dsRNA of 512B:c512B hybrids. The dsRNA was prepared by co-transcription of the two RNA strands using two independent templates and was purified using RNase I f , which selectively degrades residual ssRNA while maintaining dsRNA ( Figure 4B ). The results show 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 that Ψ, m1Ψ, m6A or m5C had little impact on the MDA5-stimulatory activity of the dsRNA
. It is noteworthy that another nucleotide modification, adenosine deamination (i.e. inosine) by the cellular enzyme ADAR1, significantly suppresses the MDA5 activity (22) (23) (24) . Given that inosine weakens Watson-Crick base-pairs, while Ψ, m1Ψ, m6A and m5C do not, this result is consistent with the notion that MDA5 primarily recognizes dsRNA backbone structure with little specific contacts with RNA bases (25) . Thus, the observed impact of Ψ, m1Ψ and m5C in lowering the immunogenicity of T7 transcript is at least in part due to their abilities to lower the dsRNA byproduct formation by T7 pol, rather than by decreasing the MDA5stimulatory activity of the dsRNA byproduct.
Low concentrations of Mg can suppress the promoter-independent antisense transcription
The above result suggested that the transcription reaction conditions can affect the dsRNA byproduct formation. We thus performed a more systematic analysis of the reaction condition using varying concentrations of individual reaction components. These include T7 pol, DNA template, NTP and MgCl 2 , of which a range of concentrations have been used in literature. We also tested an increasing concentration of NaCl, because non-specific DNA binding by T7 pol was previously shown to be suppressed in buffers with high ionic strength (26) . By both in-house produced T7 pol (hT7 pol) and commercial T7 pol (cT7 pol), we observed little dependence of the dsRNA byproduct formation on the concentration of T7 pol ( Figure 5A ). Concentrations of the template, NTP and NaCl also had a minimal impact on the level of dsRNA byproduct formation (Figures 5B-D). Intriguingly, decreasing the concentration of MgCl 2 from 30 mM to 5 mM significantly reduced dsRNA byproduct formation, to the point that dsRNA was barely detectable at 5 mM MgCl 2 ( Figure 5E ). Note that the total yield of RNA was not significantly affected by the reduction in MgCl 2 . This was unexpected because it is often considered necessary to use MgCl 2 in excess over NTP (which is 20 mM in total). The observed impact of MgCl 2 on dsRNA production was similarly observed with the MDA5 ATPase assay, which showed that decreasing concentration of MgCl 2 reduced the level of the ATPase activity ( Figure 5F ).
To examine whether the observed impact of MgCl 2 on dsRNA byproduct formation is generally applicable, we examined other templates with varying DNA sequences, structure and lengths. In 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 all cases, including the one with a 3' overhang (KpnI-ad), we found that reducing MgCl 2 from 30 mM to 5 mM significantly lowered the level of dsRNA byproduct, as measured by both native gel analysis and MDA5 ATPase assay ( Figures 5G & 5H ). Although additional ssRNA bands appear for some RNAs at low MgCl 2 (Figure 5G ), the overall lack of dsRNA byproduct suggests that lowering the MgCl 2 concentration can be used as a general method to suppress the aberrant dsRNA byproduct formation.
DISCUSSION
It has been known that T7 in vitro transcripts are often immunogenic. However, the precise origin of the immunogenicity−i.e. the identity of the RNA species and its immune-stimulatory mechanism−has been unclear. This study provides an answer to these questions by showing that T7 pol often produces long dsRNA byproducts that can robustly activate the cytosolic sensors RIG-I and MDA5 in 5'ppp-dependent and -independent manners. The dsRNA is formed by hybridization of the intended sense transcript and its fully complementary antisense transcript.
The antisense RNA is produced by promoter-independent transcriptional initiation from a DNA end, which differs from previously reported erroneous behaviors of T7 pol, such as 3'-extension of RNA, RNA-dependent RNA polymerization and DNA-primed RNA synthesis (16) (17) (18) 27 ).
Our finding also shows that this promoter-independent transcription is observed with a wide range of DNA templates, and is not limited to the DNA end with 3' overhangs as previously reported (19) . Thus, our work highlights yet another level of complexity of T7 pol activity, and has broad implications for studies utilizing T7-transcribed RNAs.
Our work also offers novel methods to quantitatively detect such dsRNA byproduct formation.
While previous studies often utilized dsRNA-specific antibodies, such as J2, for detecting dsRNA, such methods cannot distinguish between secondary structures within ssRNA vs. long dsRNA byproducts formed by sense-antisense hybridization. Instead, we propose the MDA5 filament formation and ATPase assays as robust and convenient methods to quantitatively measure dsRNA contaminants, either in T7 pol transcripts or in any other RNA products. In particular, MDA5 filament analysis by EM allows one to examine the extent of the continuous duplex length, thereby unambiguously distinguishing between intrinsic secondary structures within ssRNA and fully duplexed RNA byproducts. Of note, our work also demands re- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 evaluation of the conventional method of determining RNA purity, i.e. denaturing gel electrophoresis. Considering that intended sense and antisense transcripts differ by ~20 nt (the size of the T7 promoter, Figure 2 ), denaturing gel would be inefficient in separating sense and antisense strands for long RNA transcripts. Instead we here used native gel electrophoresis, which allowed us to separate ssRNA and dsRNA products and to distinguish them using acridine orange staining. While native gel analysis alone can be complicated for RNAs with intrinsic secondary structures, we believe that a combination of native gel electrophoresis, MDA5 filament formation and ATPase assays would enable a comprehensive analysis of RNA transcript of interest.
Finally, our study provides previously unappreciated methods to suppress the dsRNA byproduct formation. These include using modified nucleotides and reducing MgCl 2 concentration, as well as altering template sequence in the promoter-less terminus. Unlike the conventional notion that RNA containing modified nucleotides are less immunogenic, we found that modified nucleotides in fact suppress the T7 pol's aberrant activity of generating immunogenic dsRNA byproduct, rather than decreasing the MDA5-stimulatory activity of dsRNA. We also found that Mg, among all variables tested, unexpectedly plays the most significant role in regulating dsRNA byproduct synthesis. Intriguingly, a previous study showed that HPLC purification can deplete immunestimulatory dsRNA (5) . Although the exact identity of the dsRNA byproduct in this study is not clear, an optimal transcription reaction that minimizes such byproduct formation would help in improving the purity of RNA, and could potentially alleviate the need for the HPLC purification.
Altogether, the current work provides novel insights into the previously enigmatic properties of the T7 pol-an origin, detection and regulation of the immunogenic byproduct.
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See Table S1 for the template sequence. Note that for shorter RNAs (~150 nt), dsRNA migrates more slowly than ssRNA of an equivalent size.
H. MDA5 ATPase analysis of the T7 transcripts in (G).
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Materials and Methods
Plasmids and Proteins
Mammalian expression plasmids for RIG-I and MDA5 and the bacterial expression plasmid for MDA5∆N (residue 287-1025) were described previously (15) . Protocols to express and purify MDA5∆N was reported in (25) . Briefly, the protein was expressed in BL21(DE3) at 20˚C for 16-20 hr following induction with 0.5 mM IPTG. Cells were lysed by high pressure homogenization using an Emulsiflex C3 (Avestin), and the protein was purified by a combination of Ni-NTA and heparin affinity chromatography and size exclusion chromatography (SEC) in 20 mM Hepes, pH 7.5, 150 mM NaCl and 2 mM DTT. T7 polymerase was expressed in BL21(DE3) using the plasmid pT7-911Q. The T7 pol protein was purified by Ni-NTA followed by size exclusion chromatography (SEC) in 50 mM Tris, pH 7.5, 100 mM NaCl and 1 mM EDTA, and stored in 50% glycerol.
T7 transcription
Sequences for the DNA templates are shown in Table S1 . Unless mentioned otherwise, templates for in vitro transcription were prepared by PCR reactions. Transcription was performed in the reaction containing 250 mM Hepes (pH 7.5), 30 mM MgCl 2 , 2 mM Spermidine, 40 mM DTT, 0.1 mg/ml BSA, 5 mM NTP (5 mM each), 0.5 mg/ml T7 pol and 0.25 mg/ml DNA template.
Reaction was incubated at 37˚C for 4 hr and DNA template was digested with DNase I.
Trasnscript was purified by Phenol:chloroform extraction, ethanol precipitation and using the QIAquick PCR purification kit (Qiagen). Transcripts (160 ng each) were analyzed by 1X TBE 6% polyacrylamide gel. RNAs were visualized by SybrGold staining (Thermofisher) or by acridine orange (AO, in 25 µg/ml) staining (Sigma Aldrich). Fluorescent gel images were obtained using the FLA9000 gel scanner (GE Healthcare). For the AO fluorescent images, ssRNA-specific images were obtained using the 473 nm and 792 nm filters for excitation and emission, respectively. For dsRNA-specific fluorescent images, the 532 nm and 554 nm filters were used for excitation and emission, respectively.
5'-and 3'-RACE
For 5'-RACE, transcripts were subject to reverse transcription using a primer specific to the RNA of interest. Prior to RT, the primer and RNA were incubated at 95˚C for 5 min in the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 presence of 2 mM EDTA, and cooled down to 4˚C for 2 min. High Capacity cDNA reverse transcription kit (Applied Biosystems) was used according to the manufacturer's protocol. After RT, RNA was removed with RNase A, and cDNA was purified using QIAquick PCR purification kit. The 3' end of the first strand cDNA was extended with poly A tails using the Terminal dNTP transferase (NEB). The second strand cDNA was synthesized by using the oligo d(T)-anchor primer. For 3'-RACE, 3' end of the RNA was first extended with poly A tails using the poly A polymerase (NEB). The first strand and second strand cDNAs were synthesized using the oligo d(T)-anchor primer and a primer bearing the internal sequence of the RNA of interest.
For both 5'-and 3'-RACE, the final product was PCR amplified and subjected to Sanger sequencing (Quitara Biosciences). Primers used in the analysis are shown in Table S2 . 
ATPase assay
The ATP hydrolysis activity of MDA5 was measured using Green Reagent (Enzo Life Sciences).
MDA5∆N (500 nM) was pre-incubated with RNA (2 ng/µl) in buffer A (20 mM HEPES pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 and 2 mM DTT), and the reaction was initiated by addition of 2 mM ATP at 37°C. Aliquots (10 µl) were withdrawn before and 15 min after ATP addition, and were quenched with 100 mM EDTA on ice. The Green Reagent (90 µl) was added to the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 quenched reaction at a ratio of 9:1, and OD 650 was measured using a Synergy2 plate reader (BioTek).
Electron Microscopy
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